WPD Pharmaceuticals Inc.
WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.
WPD Pharmaceuticals Inc. (WBIO)
Le 10 Janvier/January 2020
Westcot Ventures Corp. has announced a name change to WPD Pharmaceuticals Inc.
The shares will begin trading under the new name on January 14, 2020.
The symbol will remain “WBIO”.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on January 13, 2020. Dealers are reminded to re-enter their orders.